GH Research PLC (NASDAQ:GHRS) is among the best psychedelic stocks to buy in 2026. The company is advancing efforts to develop psychedelic medicines targeting conditions like depression, bipolar II disorder, and other psychiatric and neurological disorders. Its flagship drug candidate GH001 is aimed at patients with treatment-resistant depression as well as those with bipolar II disorder and postpartum depression. What Does GH Research PLC (GHRS)’s Clinical Progress Updates Say? On March 10, Guggenheim ...

AbbVie (NYSE:ABBV) is among the best psychedelic stocks to buy in 2026. AbbVie (NYSE:ABBV) expanded its psychiatry pipeline with the acquisition of psychedelic compound bretisilocin from Gilgamesh Pharmaceuticals in 2025. It paid $1.2 billion for bretisilocin, a Phase 2 psychedelic drug candidate being developed as a treatment for major depressive disorder. AbbVie has a broad portfolio of approved drugs and drug candidates targeting diverse health issues. Copyright: katrintimoff / 123RF Stock Photo On M ...